UniProtKB/Swiss-Prot Q8NFD5: Variant p.Gly1519Ala

AT-rich interactive domain-containing protein 1B
Gene: ARID1B
Feedback?

Variant information Variant position:

1519 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Alanine (A) at position 1519 (G1519A, p.Gly1519Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

The poly-Gln region is polymorphic and the number of Gln varies in the population (from 17 to 23). Additional information on the polymorphism described.
Variant description:

Found in a patient with short stature; likely pathogenic; de novo mutation. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs2128373494 [ dbSNP | Ensembl ]

Sequence information Variant position:

1519 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2319 The length of the canonical sequence.
Location on the sequence:

RERMQGPGQIQTHGIPPQMM G GPLQSSSSEGPQQNMWAARN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RERMQGPGQIQTHGIPPQMMGGPLQSSSSEGPQQNMWAARN

Mouse                         RERMQGPGQMQPHGIPPQMMGGPMQSSSSEGPQQNMWATRN

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 2319	AT-rich interactive domain-containing protein 1B
Region	1475 – 1647	Disordered
Compositional bias	1519 – 1534	Polar residues

Literature citations
De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature.
Yu Y.; Yao R.; Wang L.; Fan Y.; Huang X.; Hirschhorn J.; Dauber A.; Shen Y.;
BMC Genomics 16:701-701(2015)
Cited for: VARIANTS LEU-854; ALA-1519; LEU-1646 AND TYR-2070;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.